SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Wire to Wire Daily Stock Picking
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey L. Henken who wrote (53)5/19/1999 11:01:00 PM
From: LarryS  Read Replies (2) of 3514
 
XOMA...next biotech mover. Up 15/16 today,
up 2 1/2 in last three days. Volume jumped from
200K, 400k, 800K to 2 mil in last four days.

XOMA has released the news that one of
their Phase III trials has ended and XOMA is preparing
their presentation to the FDA. Another Phase III
will be concluded in about six months. This is
what we have been waiting for, the share price should continue to move up until presentation to FDA.
Then it is make or break...but everyone knows the
money in biotech is made after the long (expensive) trials are completed but before the FDA makes their decision.
What will the FDA decide?? Everything points to
XOMA having a great, new drug...but the FDA makes
the final decision. Do your DD then join us for
the ride.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News